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Abstract: Mass spectrometry (MS)-based precursor ion isolation, collision-induced dissociation (CID)
fragmentation, and detection using linear ion-trap multiple-stage mass spectrometry (LIT MSn) in
combination with high resolution mass spectrometry (HRMS) provides a unique tool for structural
characterization of complex mixture without chromatographic separation. This approach permits
not only separation of various lipid families and their subfamilies, but also stereoisomers, thereby,
revealing the structural details. In this report, we describe the LIT MSn approach to unveil the
structures of a 2,3-diacyl trehalose (DAT) family isolated from the cell envelope of Mycobacterium
tuberculosis, in which more than 30 molecular species, and each species consisting of up to six isomeric
structures were found. LIT MSn performed on both [M + Na]+ and [M + HCO2]− ions of DAT yield
complimentary structural information for near complete characterization of the molecules, including
the location of the fatty acyl substituents on the trehalose backbone. This latter information is based
on the findings of the differential losses of the two fatty acyl chains in the MS2 and MS3 spectra; while
the product ion spectra from higher stage LIT MSn permit confirmation of the structural assignment.
Keywords: tandem mass spectrometry; linear ion trap; glycolipid; diacyltrehalose;
Mycobacterium tuberculosis
1. Introduction
Tandem mass spectrometry is a powerful tool for structural analysis of unknown molecules.
Tandem mass spectrometry consists of several sequential events including formation and mass
selection of the precursor ions, collision induced dissociation (CID) with inert target gas for fragment
ion formation, followed by mass analysis and detection of the product-ions. For tandem mass
spectrometry with quadrupole (e.g., triple quadrupole, TSQ), sector, and hybrid Q-TOF instruments,
these processes occur sequentially in the separate regions of the instruments and the MS/MS process is
tandem-in-space. For quadrupole ion-trap (QIT) and linear ion trap (LIT) instruments, the precursor ion
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selection, CID, and product-ion analysis and detection events are all executed in the ion trap in a timing
sequence manner, and the MS/MS process is tandem-in-time [1]. Linear ion trap multiple stage tandem
mass spectrometry (LIT MSn) permits the repeat of the precursor ion selection-CID-product-ion analysis
process, and up to 10 cycles can be performed using modern commercial LIT mass spectrometers such
as Thermo LTQ Orbitrap. This instrument is also featured with an extreme high resolving power and
up to a million resolution (at m/z 200) can be reached [2].
Due to its MSn capability with high resolution, LIT/Orbitrap with MSn approach has been
widely used in the structural characterization of a wide range of biomolecules [3–7]. LIT MSn with
high resolution is also extremely useful for identification of complex lipid structures, in particular,
microbial lipid, permitting revelation of numerous isomeric molecules in lipid extracts. For example,
we demonstrated that sulfolipid II in Mycobacterium tuberculosis (M. tuberculosis) H37Rv cells is the
predominated lipid family, consisting of hundreds of molecular species rather than the sulfolipid I
family as previously reported [8,9]. LIT MSn with high resolution mass spectrometry has also been
successfully applied to delineate the structures of phosphatidylinositol mannosides (PIMs) [10,11],
and phthiocerol dimycocerosates (PDIMs) [12] in the cell envelope of M. tuberculosis. The former lipid
family is known to have played important roles in M. tuberculosis adhesins that mediate attachment
to nonphagocytic cells [13], while the latter is recently found to play role in drug resistance to
M. tuberculosis [14].
In addition to the above complex lipid families, other glycolipids found in the mycobacterial
cell wall include acylated trehaloses [15–18]. These trehalose-containing glycolipids consist of many
families [18–22], of which the 2,3-di-O-acyltrehaIose (DAT) family was previously defined as glycolipid
B. DAT is a mycobacterial factor capable of modulating host immune responses [23] and can inhibit
the proliferation of murine T cells [24]. DAT along with pentaacyl trehalose (PAT) also play an
important role in pathogenesis and a structural role in the cell envelope, promoting the intracellular
survival of the bacterium [25]. The DATs from M. tuberculosis and M. fortuitum have been shown to be
antigenic [24,26,27] and their potential use in serodiagnosis has been postulated [28,29].
Besra and coworker defined the structures of the acylated trehalose lipid family using
gas chromatography-mass spectrometry, in conjunction with normal/reversed phase TLC,
and one/two-dimensional 1H, and 13C nuclear magnetic resonance spectroscopy [21]. However,
there is no report in the detailed structural assignment of the various molecular species with many
isomeric structures for the entire lipid family.
In this report, we applied multiple stage precursor ion isolation and resonance excitation activation
to generate distinct MSn spectra to explore the structure details of the 2,3-diacyl trehalose (DAT) lipid
family found in M. tuberculosis. This study highlights the unique feature of the technique of LIT MSn
for tandem-in-time precursor ion separation that affords structural characterization of a complex lipid
family, while a similar structural analysis would be very difficult to perform utilizing the tandem mass
spectrometric approach with a sector, TSQ or QTOF instrument.
2. Materials and Methods
2.1. Materials
All solvents (spectroscopic grade) and chemicals (ACS grade) were obtained from Sigma Chemical
Co. (St. Louis, MO, USA).
2.2. Sample Preparation
M. tuberculosis strain H37Rv were grown and total lipids were extracted and isolated as previously
described [8]. Briefly, the total lipid was separated by a Phenomenex C18 Kinetex (100 × 4.6 mm,
pore size 100 Å, particle size 2.6 µm) column at a flow rate of 300 µL/min with a gradient system as
previously described [12]. DAT (eluted at 24.45–26.43 min) fraction from three injections (~200 µg total
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lipid/injection) were collected and pooled, dried under a stream of nitrogen, and stored at −20 ◦C
until use.
2.3. Mass Spectrometry
Both high-resolution (R = 100,000 at m/z 400) low-energy CID and higher collision-energy
dissociation (HCD) tandem mass spectrometric experiments were conducted on a Thermo Scientific
(San Jose, CA, USA) LTQ Orbitrap Velos mass spectrometer (MS) with Xcalibur operating system.
Samples in CH3OH were infused (1.5 µL/min; ~10 pmol/µL) to the ESI source, where the skimmer
was set at ground potential, the electrospray needle was set at 4.0 kV, and temperature of the heated
capillary was 300 ◦C. The automatic gain control of the ion trap was set to 5 × 104, with a maximum
injection time of 100 ms. Helium was used as the buffer and collision gas at a pressure of 1 × 10−3
mbar (0.75 mTorr). The MSn experiments were carried out with an optimized relative collision energy
ranging from 25–35% and with an activation q value at 0.25. The activation time was set for 10 ms to
leave a minimal residual abundance of precursor ion (around 20%). For the HCD experiments, the
collision energy was set at 50–55% and mass scanned from m/z 100 to the upper m/z value that covers
the precursor ions. The mass selection window for the precursor ions was set at 1 Da wide to admit the
monoisotopic peak to the ion-trap for collision-induced dissociation (CID) for unit resolution detection
in the ion-trap or high resolution accurate mass detection in the Orbitrap mass analyzer. Mass spectra
were accumulated in the profile mode, typically for 3–10 min for MSn spectra (n = 2,3,4).
2.4. Nomenclature
To facilitate data interpretation, the following abbreviations were adopted. The abbreviation
of the long-chain fatty acid such as the stearic acid attached to the C2 position of the trehalose
backbone is designated as 18:0. The multiple methyl-branched mycolipenic acid, for example,
the 2,4,6-trimethyl-2-tetracosenoic acid attached to the C3-position is designated as 27:1 to reflect
the fact that the acid contains a C27 acyl chain with one double bond. Therefore, the DAT species
consisting of 18:0- and 27:1-FA substituents at C2-, and C3-position, respectively, is designated as
18:0/27:1-DAT.
3. Results and Discussion
DAT formed [M + Alk]+ ions (Alk = NH4, Li, Na, etc.) in the positive ion mode; and [M + X]−
(X = Cl, RCO2; R = H, CH3, C2H5, etc.) ions in the negative-ion mode when subjected to ESI in the
presence of Alk+ and X−. For example, when dissolved in CH3OH with the presence of HCO2Na,
adduct ions in the fashions of [M + Na]+ (Figure 1) in the positive ion mode and [M + HCO2]− ions
(data not shown) in the negative ion mode were observed. The formation of these adduct ions was
revealed by the elemental composition of the molecular species deduced by high resolution mass
spectrometry (Table 1). Upon being subject to CID in a linear ion-trap, the MSn (n = 2,3,4) spectra of
both the [M + Na]+ and [M + HCO2]− ions contain rich structural information readily applicable for
structural identification.
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Table 1. The high resolution mass measurements of the [M + Na]+ ions of DATs isolated from M.
tuberculosis and the assigned structues (* structure not defined).
Measured
m/z
Theo.
Mass m/z
Deviation
mmu
Rel.
Intensity %
Ele.
Composition
Major
structures Minor structures
935.6436 935.6430 0.55 3.42 C51H92O13Na 14:1/25:1 12:1/27:1
937.6594 937.6587 0.73 4.34 C51H94O13Na 14:0/25:1 12:0/27:1; 16:1/23:0;15:1/24:0; 13:0/26:1
939.6747 939.6743 0.37 1.48 C51H96O13Na *
949.6585 949.6587 −0.19 6.58 C52H94O13Na 16:1/24:1
951.6742 951.6743 −0.15 20.8 C52H96O13Na 16:1/24:0
16:0/24:1; 15:0/25:1;
17:1/23:0; 14:0/26:1;
13:0/27:1
953.6898 953.6900 −0.12 18.49 C52H98O13Na 16:0/24:0
961.6587 961.6587 0.01 4.31 C53H94O13Na *
963.6743 963.6743 −0.05 44.16 C53H96O13Na 16:1/25:1;14:1/27:1
965.6898 965.6900 −0.12 50.07 C53H98O13Na 16:0/25:1 14:0/27:1; 18:0/23:1
967.7054 967.7056 −0.22 12.26 C53H100O13Na 18:0/23:0;17:0/24:0 16:0/25:0
975.6740 975.6743 −0.3 3.03 C54H96O13Na *
977.6899 977.6900 −0.06 25.16 C54H98O13Na 16:1/26:1
979.7056 979.7056 −0.06 54.48 C54H100O13Na 18:0/24:1;18:1/24:0
16:0/26:1; 17:0/25:1;
16:1/26:0; 15:0/27:1
981.7211 981.7213 −0.15 62.62 C54H102O13Na 18:0/24:0 17:0/25:0; 16:0/26:0
989.6898 989.6900 −0.17 18.03 C55H98O13Na 16:1/27:2
991.7054 991.7056 −0.2 100 C55H100O13Na 16:1/27:1 18:1/25:1; 16:0/27:2;17:0/26:2
993.7210 993.7213 −0.29 95.91 C55H102O13Na 16:0/27:1 18:0/25:1; 17:0/26:1
1005.7211 1005.7213 −0.2 34.31 C56H102O13Na 16:1/28:1;17:1/27:1
17:0/27:2; 18:1/26:1;
18:0/26:2
1007.7366 1007.7369 −0.31 51.54 C56H104O13Na 17:0/27:1 16:0/28:1; 18:0/26:1;19:0/25:1; 16:1/28:0
1009.7518 1009.7526 −0.75 7.65 C56H106O13Na 18:0/26:0 20:0/24:0
1017.7209 1017.7213 −0.38 11.79 C57H102O13Na 18:1/27:2
1019.7367 1019.7369 −0.25 52.39 C57H104O13Na 18:1/27:1 18:0/27:2; 17:1/28:1
1021.7522 1021.7526 −0.37 92.1 C57H106O13Na 18:0/27:1 17:0/28:1
1033.7521 1033.7526 −0.47 10.49 C58H106O13Na 18:1/28:1 19:0/27:2; 19:1/27:1;18:0/28:2; 19:0/27:2
1035.7678 1035.7682 −0.45 13.33 C58H108O13Na 19:0/27:1;18:0/28:1 18:1/28:0; 17:0/29:1
1047.7677 1047.7682 −0.5 2.56 C59H108O13Na 18:0/28:2
1049.7835 1049.7839 −0.31 5.47 C59H110O13Na 19:0/28:1 20:0/27:1; 18:0/29:1;17:0/30:1
1061.7837 1061.7839 −0.19 1.63 C60H110O13Na 18:1/30:1
1063.7991 1063.7995 −0.38 1.83 C60H112O13Na 18:0/30:1
Separations 2019, 6, 4 5 of 14
Separations 2018, 5, x FOR PEER REVIEW  4 of 14 
 
Figure 1. The positive-ion ESI mass spectrum of the [M + Na]+ ions of the DAT species isolated from cell 
envelope of M. tuberculosis.  
Table 1. The high resolution mass measurements of the [M + Na]+ ions of DATs isolated from M. 
tuberculosis and the assigned structues (* structure not defined). 
Measured 
m/z 
Theo. 
Mass m/z 
Deviation 
mmu 
Rel. 
Intensity % 
Ele. 
Composition 
Major 
structures 
Minor structures 
935.6436 935.6430 0.55 3.42 C51H92O13Na 14:1/25:1 12:1/27:1 
937.6594 937.6587 0.73 4.34 C51H94O13Na 14:0/25:1 12:0/27:1; 16:1/23:0; 15:1/24:0; 
13:0/26:1 
939.6747 939.6743 0.37 1.48 C51H96O13Na *  
949.6585 949.6587 −0.19 6.58 C52H94O13Na 16:1/24:1  
951.6742 951.6743 −0.15 20.8 C52H96O13Na 16:1/24:0 16:0/24:1; 15:0/25:1; 17:1/23:0; 
14:0/26:1; 13:0/27:1 
953.6898 953.6900 −0.12 18.49 C52H98O13Na 16:0/24:0  
961.6587 961.6587 0.01 4.31 C53H94O13Na *  
963.6743 963.6743 −0.05 44.16 C53H96O13Na 16:1/25:1; 
14:1/27:1 
 
965.6898 965.6900 −0.12 50.07 C53H98O13Na 16:0/25:1 14:0/27:1; 18:0/23:1 
967.7054 967.7056 −0.22 12.26 C53H100O13Na 18:0/23:0; 
17:0/24:0 
16:0/25:0 
975.6740 975.6743 −0.3 3.03 C54H96O13Na *  
977.6899 977.6900 −0.06 25.16 C54H98O13Na 16:1/26:1  
979.7056 979.7056 −0.06 54.48 C54H100O13Na 18:0/24:1; 
18:1/24:0 
16:0/26:1; 17:0/25:1; 16:1/26:0; 
15:0/27:1 
981.7211 981.7213 −0.15 62.62 C54H102O13Na 18:0/24:0 17:0/25:0; 16:0/26:0 
989.6898 989.6900 −0.17 18.03 C55H98O13Na 16:1/27:2  
991.7054 991.7056 −0.2 100 C55H100O13Na 16:1/27:1 18:1/25:1; 16:0/27:2; 17:0/26:2 
993.7210 993.7213 −0.29 95.91 C55H102O13Na 16:0/27:1 18:0/25:1; 17:0/26:1 
1005.7211 1005.7213 −0.2 34.31 C56H102O13Na 16:1/28:1; 
17:1/27:1 
17:0/27:2; 18:1/26:1; 18:0/26:2 
1007.7366 1007.7369 −0.31 51.54 C56H104O13Na 17:0/27:1 16:0/28:1; 18:0/26:1; 19:0/25:1; 
16:1/28:0 
1009.7518 1009.7526 −0.75 7.65 C56H106O13Na 18:0/26:0 20:0/24:0 
1017.7209 1017.7213 −0.38 11.79 C57H102O13Na 18:1/27:2  
1019.7367 1019.7369 −0.25 52.39 C57H104O13Na 18:1/27:1 18:0/27:2; 17:1/28:1 
Figure 1. The positive-ion ESI mass spectrum of the [M + Na]+ ions of the DAT species isolated from
cell envelope of M. tuberculosis.
3.1. The Fragmentation Processes of the [M + Na]+ Ions of DAT Revealed by LIT MSn
The utility in the performance of sequential precursor ion separation, CID, and acquiring MSn
spectra of LIT MSn mass spectrometry permits insight into not only the fragmentation processes,
but also the structural details of the molecules. For example, the LIT S2 spectrum of the [M + Na]+
ions of 18:0/27:1-DAT at m/z 1021 contained the dominated ion of m/z 859 (Figure 2a) arising
from loss of glucose residue, along with the ion set at m/z 737 and 613, arising from losses of 18:0-,
and 27:1-fatty acid substituents, respectively (Scheme 1). The ions of m/z 859 represent the sodiated
diacylglucose with both the 18:0-, and 27:1-fatty acyl substituents. This notion is further supported by
the MS3 spectrum of the ions of m/z 859 (1021→ 859, Figure 2b) which contained ions of m/z 575
(859 – 284) and 451 (859 – 408), arising from losses of 18:0-, and 27:1-fatty acid substituents, respectively.
The results also suggest that the Na+ charge site most likely resides at the glucose ring with the two
acyl groups (Glc 1). In contrast, the MS2 spectrum of the [M + Na]+ ions of the 6,6′-dioleoyltrehalose
standard [30] at m/z 893 forms abundant ions at m/z 467, representing the sodiated oleoylglucose
(data not shown), consistent with the fact that the 18:1 fatty acyl substituents in the 18:1/18:1-DAT
are located on the separate Glc (i.e., Glc1 and Glc 2). Further dissociation of the ions of m/z 737
(1013→ 737, Figure 2c) gave rise to the prominent ions of m/z 329 by loss of 27:1-fatty acid substituent,
and m/z 575, arising from loss of glucose residue (Glc 2), together with m/z 431 representing a sodiated
ion of 27:1-FA. These results further support the fragmentation processes as proposed in Scheme 1.
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The formation of the ions of m/z 575 from m/z 859 by loss of 18:0-FA residue at C2 may involve
the participation of the hydrogen atom at C1 to form an enol, which undergoes enol-keto tautomerism
to yield a stable sodiated ion of monoacyl (27:1) glucose as the keto form (Scheme 1). This fragmentation
processes are further supported by MS4 on the ions of m/z 575 (1013→ 859→ 575, Figure 2d), which
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yielded ions of m/z 545, 515, and 475, likely arising from the across cleavages of the glucose ring,
suggesting that the 27:1-fatty acyl substituent is located at C3 (Scheme 1).
Similarly, MS4 on the ion of m/z 451 (1013 → 859 → 451, Figure 2e) gave rise to ions of m/z
421, 391, and 361 arising from the similar rupture of the glucose ring, indicating that the 18:0-fatty
acyl substituent is most likely located at C2 of the glucose ring. The preliminary loss of the 27:1-FA
substituent may involve the participation of the adjacent hydrogen at C4 of Glc 1 to form an enol,
which sequentially rearranges to keto form via the similar enol-keto tautomerism mechanism.
The preferential formation of the ions of m/z 575 from loss of the 18:0-FA substituent over the
ions of m/z 451 from similar loss of the 27:1-FA as seen in Figure 2a is readily applicable for locating
the FA substituents on the trehalose backbone.
3.2. LIT MSn on the [M + Na]+ Ions of DAT for Stereoisomer Recognition
To define the structures of DAT species with many isomeric structures using LIT MSn is
exemplified by characterization of the [M + Na]+ ions of m/z 979, which gave rise to the prominent
ions at m/z 817 (Figure 3a) arising from loss of glucose. Further dissociation of the ions of m/z 817
(979→ 817; Figure 3b) yielded the ion pairs of m/z 533/451, arising from losses of 18:0/24:1 fatty acid
substituents, indicating that the these two acyl groups are situated at Glc 1, giving assignment of the
18:0/24:1-DAT structure. The spectrum also contained the m/z 535/449, 561/423, 547/437, 563/421,
575/409 ion pairs, arising from losses of 18:1/24:0, 16:0/26:1, 17:0/25:1, 16:1/26:0, and 15:0/27:1 FA
pairs, respectively. The results indicate the presence of the 18:1/24:0-, 16:0/26:1-, 17:0/25:1-, 16:1/26:0-,
and 15:0/27:1-DAT isomers. The above structure assignments were further confirmed by the MS3
and MS4 spectra. For example, the MS3 spectrum of the ions of m/z 697 (979→ 697; Figure 3c) from
primary loss of a 18:1-FA residue at C2 (Figure 3a) gave the abundant ions of m/z 535 (loss of Glc 2),
along with ions of m/z 329 arising from loss of 24:0-FA substituent, and of m/z 391, representing a
sodiated 24:0-FA cation. The results confirm the presence of 18:1/24:0-DAT. The MS4 spectrum of the
ions of m/z 535 (979→ 817→ 535; Figure 3d) contained ions of m/z 517 (loss of H2O) and 505, 475,
445 arising from cleavages of the sugar ring similar to that shown in Scheme 1, along with ions of m/z
167 from loss of 24:0-FA, pointing to notion that the 24:0-FA is located at C3.
The MS3 spectrum of the ions of m/z 695 (979→ 695; Figure 3e) contained the ions of m/z 533
and 329 arising from further losses of Glc and 24:1-FA residues (Figure 3a), respectively. The MS4
spectrum of the ions of m/z 533 (979→ 817→ 533; data not shown) gave ions of m/z 503, 473, and 443
from the similar fragmentation processes that cleave the sugar ring (Scheme 1), confirming that the
24:1-FA substituent is located at C3. The results led to assign the 18:0/24:1-DAT structure. Using this
LIT MSn approach, a total of six isomeric structures were identified.
3.3. The Fragmentation Processes of the [M + HCO2]− Ions of DAT Revealed by LIT MSn
In the negative-ion mode in the presence of HCO2−, 18:0/27:1-DAT formed [M + HCO2]− ions of
m/z 1043, which gave rise to the prominent ions of m/z 997 by loss of HCO2H, along with ions of m/z
713 and 589 by further losses of 18:0- and 27:1-FA substituents, respectively (Figure 4a) (Scheme 2).
This fragmentation process is further supported by the MS3 spectrum of the ions of m/z 997 (1043
→ 997, Figure 4b), which are equivalent to the [M − H]− ions of 18:0/27:1-DAT. The ions of m/z 731
(Figure 4a) arising from loss of 18:0-FA as a ketene is more prominent than the ions of m/z 607 arising
from analogous 27:1-ketene loss. This preferential formation of m/z 731 corresponding to loss of the
FA-ketene at C2 over ions of m/z 607 from the FA-ketene loss at C3 was seen in all the MS2 spectra
of the [M + HCO2]− ions of DAT, providing useful information for distinction of the FA substituents
at C2 and C3. The ketene loss process probably involves the participation of HCO2−, which attracts
the labile α-hydrogen on the fatty acid group to eliminate FA-ketene and HCO2H simultaneously
(Scheme 2). Therefore, the low abundance of the ions of m/z 607 arising from loss of the FA-ketene at
C3 may reflect the fact that the 27:1-FA substituent at C3 contains an α-methyl side chain [19,21,22,31],
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and does not contain labile α-hydrogen required for ketene loss. This is in contrast to the 18:0-FA
substituent at C2, which possesses two α-hydrogens (Scheme 2).
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817 (9 9→ 817)) (b), of m/z 697 (979→ 697) (c), its MS4 spectrum of the ions of m/z 53 (979→ 817
→ 535) (d); and the MS3 spectrum of the ions of m/z 695 (979→ 695) (e).
Separations 2018, 5, x FOR PEER REVIEW  8 of 14 
of the ions of m/z 533 (979 → 817 → 533; data not shown) gave ions of m/z 503, 473, and 443 from the 
similar fragmentation processes that cleave the sugar ring (Scheme 1), confirming that the 24:1-FA 
substituent is located at C3. The results led to assign the 18:0/24:1-DAT structure. Using this LIT MSn 
approach, a total of six isomeric structures were identified. 
3.3. The Fragmentation Processes of the [M + HCO2]− Ions of DAT Revealed by LIT MSn 
In the negative-ion mode in the presence of HCO2−, 18:0/27:1-DAT formed [M + HCO2]− ions of m/z 
1043, which gave rise to the prominent ions of m/z 997 by loss of HCO2H, along with ions of m/z 713 and 
589 by further losses of 18:0- and 27:1-FA substituents, respectively (Figure 4a) (Scheme 2). This 
fragmentation process is further supported by the MS3 spectrum of the ions of m/z 997 (1043 → 997, 
Figure 4b), which are equivalent to the [M − H]− ions of 18:0/27:1-DAT. The ions of m/z 731 (Figure 4a) 
arising from loss of 18:0-FA as a ketene is more prominent than the ions of m/z 607 arising from analogous 
27:1-ketene loss. This preferential formation of m/z 731 corresponding to loss of the FA-ketene at C2 over 
ions of m/z 607 from the FA-ketene loss at C3 was seen in all the MS2 spectra of the [M + HCO2]− ions of 
DAT, providing useful information for distinction of the FA substituents at C2 and C3. The ketene loss 
process probably involves the participation of HCO2−, which attracts the labile α-hydrogen on the fatty 
acid group to eliminate FA-ketene and HCO2H simultaneously (Scheme 2). Therefore, the low abundance 
of the ions of m/z 607 arising from loss of the FA-ketene at C3 may reflect the fact that the 27:1-FA 
substit ent at C3 contains an α-m thyl side chain [19,21,22,31], and do s not contain labile α-hydrogen 
required for ketene loss. This is in contrast to the 18:0-FA sub tituent at C2, which possesses two α-
hydrogens (Scheme 2). 
 
Figure 4. The negative-ion MS2 spectrum of the [M + HCO2]− ions of 18:0/27:1-DAT at m/z 1043 (a), its MS3 
spectrum of the ions of m/z 997 (1043 → 997) (b). 
Figure 4. ti e-ion MS2 spectrum of the [M + HCO2]− ions of 18:0/27:1-DAT at m/z 1043 (a),
its MS3 spectrum of the ions of m/z 997 (1043→ 997) (b).
Separations 2019, 6, 4 9 of 14
Separations 2018, 5, x FOR PEER REVIEW  9 of 14 
O
O
O
OH
OH
OH
O
HO
HO
O
OH
O
C17H35
- (HCO2H + 18:0-KETENE)
loss of 27:1-FA
1043
731
323
- HCO2H
O
O
O
OH
OH
O
O
HO
HO
O
O
O
O
C17H35
C14H29
407
997
O
O
O
OH
OH
O
HO
HO
O
O
O
C14H29
589
231
H
loss of 27:1-FA
283
305
loss of 18:0-FA
589
407
283
713
O
O
O
OH
OH
O
HO
HO
O
O
loss of 18:0-FA
713
loss of 27:1-FA
305
MS2
MS2
MS3
MS3
MS4
MS4
I
2
HC
O
O
O
O
O
OH
OH
OH
O
HO
HO
O
OH
O
C17H35
O
H
C14H29
1
2
3
4
5
6
 
Scheme 2. The proposed LIT MSn fragmentation processes of the [M + HCO2]− ions of 18:0/27:1-DAT at m/z 1043. 
The ions at m/z 731 and 607 arising from losses of 18:0-ketene and 27:1-ketene, respectively, are 
absent in Figure 4b. This is consistent with the notion that the ketene loss requires the participation of 
HCO2−. The ketene loss pathway becomes not operative after the [M − H]− ions are formed from [M + 
HCO2]− by loss of HCO2H. 
The spectrum (Figure 4b) also contained the prominent ions of m/z 407, representing 27:1-fatty acid 
carboxylic anions, and the ions of m/z 283 representing 18:0-FA carboxylate anions, along with ions of 
m/z 305 arising from losses of both 18:0- and 27:1-FA substituents. The preferential formation of the ions 
of m/z 407 (at C3) over m/z 283 (at C2) is also a reflection of the location of the fatty acid substituents on 
the Glc ring, leading to the assignment of 18:0/27:1-DAT structure. 
3.4. Recognition of Stereoisomers Applying LIT MSn on the [M + HCO2]− Ions 
Similarly, the MS2 spectrum of the ions of m/z 1001 is dominated by the ions of m/z 955 from loss of 
HCO2H (Figure 5a). The MS3 spectrum of the ions of m/z 955 (1001 → 955) (Figure 5b) contained ions at 
m/z 701, 699, 685, 673, 671, 589, 587, 575, 561, 559, similar to those seen in Figure 5a, consistent with the 
consecutive dissociation processes of the [M − H]− ions that eliminate the FA substituents. These ions 
arose from losses of 16:1-, 16:0-, 17:0-, 18:1-, 18:0-, 24:1-, 24:0-, 25:0-, 26:1, and 26:0-fatty acid substituents, 
respectively. The spectrum also contained the major m/z 283/365, 281/367 ion pairs, together with the 
minor ion pairs of m/z 255/393, 253/395, 269/379, 241/407. These structural information led to assignment 
of the major 18:0/24:1-, and 18:1/24:0-DAT isomers, together with the 16:0/26:1-, 16:1/26:0-, 17:0/25:1, and 
15:0/27:1-DAT minor isomers. It should be noted that the absence of ions at m/z 241, 253, 255, and 269 
representing 15:0-, 16:1-, 16:0-, and 17:0-carboxylate anions, respectively, in Figure 5b, are attributable to 
the low mass cutoff nature of an ion-trap instrument. In contrast, these ions are abundant in the HCD 
production ion spectrum (data not shown), similar to that obtained by a triple quadrupole instrument 
[32]. The location of the fatty acid substituent position on the glucose skeleton is again confirmed by 
observation of the ions corresponding to loss of the fatty acid substituents as ketenes. For example, ions 
at m/z 691 and 689 (Figure 5a) derived from losses of (HCO2H + 18:1-ketene) and (HCO2H + 18:0-ketene), 
respectively, pointing to the notion that both 18:1- and 18:0-FA are situated at C2 of the 18:1/24:0-, and 
Scheme 2. The pr posed LIT MSn fragmentation proc ses of the [M + HCO2]− ions of 18:0/27:1-DAT
at m/z 1043.
The ions at m/z 731 and 607 arising from losses of 18:0-k tene and 27:1-ketene, res ectively, are
absent in Figur 4b. Thi is consistent with the n tion hat the ketene loss requires the participation of
HCO2−. The ketene loss pathway becomes not operative after the [M − H]− ions are formed from
[M + HCO2]− by loss of HCO2H.
The spectrum (Figure 4b) also contained th prominent ions of m/z 407, representi 27:1-fatty
acid carboxyl c ani ns, and the i ns of m/z 283 repre enting 18:0-FA ca boxylate anions, along with
ions of m/z 305 arising from losses of both 18:0- and 27:1-FA substituents. T preferential formation
of the ions of m/z 407 (at C3) over m/z 283 (at C2) is also a reflection of the location of the fatty acid
substituents on the Glc ring, leading to the assignment of 18:0/27:1-DAT structure.
3.4. Recognition of Stereoisomers Applying LIT MSn on the [M + HCO2]− Ions
Similarly, the MS2 spectrum of the ions of m/z 1001 is dominated by the ions of m/z 955 from l s
of HCO2H (Figure 5a). The MS3 spectrum of the ions of m/z 955 (1001→ 955) (Figure 5b) contained
ions at m/z 701, 699, 685, 673, 671, 589, 587, 575, 561, 559, similar to those s en in Figure 5a, consist nt
with the consecutive dissociation processes of the [M − H]− ions that eliminate the FA substituents.
These ions arose from losses of 16:1-, 16:0-, 17:0-, 18:1-, 18:0-, 24:1-, 24:0-, 25:0-, 26:1, and 26:0-fatty
acid substituents, respectively. The spectrum also contained the major m/z 283/365, 281/367 ion
pairs, together with the minor ion pairs of m/z 255/393, 253/395, 269/379, 241/407. These structural
information led to assignment of the major 18:0/24:1-, and 18:1/24:0-DAT isomers, together with the
16:0/26:1-, 16:1/26:0-, 17:0/25:1, and 15:0/27:1-DAT minor isomers. It should be noted that the absence
of ions at m/z 241, 253, 255, and 269 representing 15:0-, 16:1-, 16:0-, and 17:0-carboxylate anions,
respectively, in Figure 5b, are attributable to the low mass cutoff nature of an ion-trap instrument.
In contrast, these ions are abundant in the HCD production ion spectrum (data not shown), similar to
that obtained by a triple quadrupole instrument [32]. The location of the fatty acid substituent position
on the glucose skeleton is again confirmed by observation of the ions corresponding to loss of the fatty
acid substituents as ketenes. For example, ions at m/z 691 and 689 (Figure 5a) derived from losses of
(HCO2H + 18:1-ketene) and (HCO2H + 18:0-ketene), respectively, pointing to the notion that both 18:1-
and 18:0-FA are situated at C2 of the 18:1/24:0-, and 18:0/24:1-DAT isomers, respectively. The assigned
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structure of 18:0/24:1-DAT, for example, is further confirmed by MS4 on the ions of m/z 671 (1001→
955→ 671) (Figure 5c), which formed ions of m/z 365, representing a 24:1-carboxylate anion, and ions
of m/z 323 and 305 arising from further loss of 24:1-FA substituent as ketene and FA, respectively.
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Figure 5. The negative-ion MS2 spectrum of the [M + HCO2]− i ns of m/z 1001 (a), its MS3 spectrum
f the ions of m/z 955 (1001→ 955) (b), and th MS4 spectrum of the ions of m/z 671 (1001→ 955→
671) (c).
3.5. Characterization of Minor Species Applying LIT MSn on the [M + HCO2]− Ions
Applying multiple-stage mass spectrometry (LIT MSn) for consecutive ion separation followed
by CID mass spectrometry is particularly useful for characterization of inor DAT species as
[M + HCO2]− ions. For example, the MS2 spectrum of the [M + HCO2]− ion of the minor DAT
at m/z 989 (Figure 6a) gave a m jor [M − H]− fragment ions at m/z 943, but the sp ctrum also
contained many unrelate fragment ions (e.g., ions of m/z 957, 930, 921, an 905) that complicate the
structural identification. The fragment ions may rise fr m the adjacent pr cursor ions admitted
together with the esired DAT ions for CID, due to th t the precursor i n s lection window (1 Da)
cannot sufficiently isolate th isobar c ions (the mass selection window and injection time govern the
total ions ad itt d to th trap for CID and >1 Da m ss selection window is often required to maintain
the sensitivi y). Thus, fragment ions unrelated to the targeted molecule were formed simultaneously
and complicating the structure analysis. However, th MS3 spectr m of m/z 943 (Figure 6b) contained
only the fragment ions related to the DAT species, due to that the [M − H]− ions still retai t e
complete structure but have been further segregated, and fragment ions unrelated to the structure
have been filtrated by another stage (MS3) isolation. In this context, the MS4 spectrum of the ions of
m/z 589 (989→ 943→ 589; Figure 6c), which were further “purified”, becomes even more specific,
due to that only the fragment ions from DAT that consists of 23:0-FA substituent at C3 were subjected
to further CID. Thus, the spectrum only contained ions of m/z 283, representing a 18:0-carboxylate
anion, along with ions at m/z 323 and 305, representing the dehydrated trehalose anions. These results
led to specifically define the 18:0/23:0-DAT structure. The spectrum (Figure 6b) also contained the
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m/z 269/367 and 255/381 ion pairs, representing the 17:0/24:0-, 16:0/25:0-FA carboxylate anion
pairs, together with ions of m/z 687/561 and 673/575 ion pairs, arising from losses of 17:0/24:0-,
16:0/25:0-FA substituents, respectively. These results readily led to the assignment of 17:0/24:0- and
16:0/25:0-DAT isomeric structures.
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Fi r . he negative-ion MS2 spectrum of the [M + HCO2]− ions of DAT at m/z 989 (a), its MS3
spectrum of the ions of m/z 43 989→ 943) (b), MS4 spectrum of the ions of m/z 589 (989→ 943→
589) (c). The ions of m/z 989 are minor ecies and i s MS2 spectrum contains several ions (shown in
red in (a)) unrelated to the struc ure, but av been filtrated fr m h gher stage MSn, as shown in (b)
(MS3) and (c) (MS4).
4. Conclusions
Sequential precursor ion isolation applying multiple-stage mass spectrometry (LIT MSn) adds
another di ension of separation in the analysis, providing a powerf l tool for structural identification
of various compounds. Thereby, many isomeric structures of t e molecule can be unveiled in a very
short period of time. By contrast, using the conventi al chromatograp c separ tion combin d
with a TSQ or QTOF instrument, th consecutive precursor ion isolation by MS is not achievabl ,
and the species s parati n can only rely on column separa ion. Thu , complete separation of a
complex lipid mixture with a wide range of molecular species and many isomeri structures is often
difficult. Compound separation by chromatographic means also requires significantly more times [33],
as compared to the LIT MSn approach, by which the separation-CID-detection process can be completed
within a very short period of time.
LIT MSn permits ion isolation in the time sequence manner, and the separation of ions is flexible
(i.e., the types of ions selected and the mass selection window of precursor ions). The selected ions
become more specific, and the MSn spectrum provides more structurally specific information as
the MSn stage advances, therefore, resulting in a confident and detailed structural identification.
The structures of minute ion species that are often difficult to define by other analytical method can
also be assigned (Table 1). However, the sensitivity declines as the higher order of MSn stage proceeds.
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Other drawback includes that a complete structural information is not necessary extractable by MSn.
For example, the positions of the double bond and methyl side chain of the fatty acid substituents at
C3 have not been defined in this study.
The LIT MSn approach as described here affords near complete structural characterization of a
complex DAT lipid family, locating the fatty acyl groups on the trehalose backbone, and recognizing
many isomeric structures. A LIT MSn approach combined with chemical reaction modification [9,34]
for locating the functional groups including the methyl, hydroxyl, and the double bond on the fatty
acid substituents are currently in progress in our laboratory.
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